These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships. Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246 [TBL] [Abstract][Full Text] [Related]
23. Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors. Van Den Beukel I; Dijcks FA; Vanderheyden P; Vauquelin G; Oortgiesen M J Pharmacol Exp Ther; 1997 Jun; 281(3):1113-9. PubMed ID: 9190843 [TBL] [Abstract][Full Text] [Related]
24. Antispasmodic action of propinox on the isolated human gallbladder: possible mechanism of action. Baistrocchi RL; Orti E; de los Santos AR; Di Girolamo G; Marti ML; Pico JC Acta Physiol Pharmacol Ther Latinoam; 1999; 49(3):161-9. PubMed ID: 10797855 [TBL] [Abstract][Full Text] [Related]
25. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation]. Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176 [TBL] [Abstract][Full Text] [Related]
26. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Ward TR; Ferris DJ; Tilson HA; Mundy WR Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012 [TBL] [Abstract][Full Text] [Related]
27. Batrachotoxin changes the properties of the muscarinic receptor in rat brain and heart: possible interaction(s) between muscarinic receptors and sodium channels. Cohen-Armon M; Kloog Y; Henis YI; Sokolovsky M Proc Natl Acad Sci U S A; 1985 May; 82(10):3524-7. PubMed ID: 2582418 [TBL] [Abstract][Full Text] [Related]
28. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum. Nilvebrant L; Sparf B Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the antimuscarinic action of p-fluorohexahydrosiladifenidol in ileal and tracheal smooth muscle. Ehlert FJ; Hsu JC; Leung K; Lee AG; Shehnaz D; Griffin MT J Pharmacol Exp Ther; 2005 Feb; 312(2):592-600. PubMed ID: 15456838 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain. Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753 [TBL] [Abstract][Full Text] [Related]
31. Antimuscarinic oxotremorine analogs distinguish high and low affinity agonist states of muscarinic receptors. Ringdahl B; Amstutz R; Closse A Proc West Pharmacol Soc; 1988; 31():57-60. PubMed ID: 3211922 [No Abstract] [Full Text] [Related]
32. Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation. Tasso B; Budriesi R; Vazzana I; Ioan P; Micucci M; Novelli F; Tonelli M; Sparatore A; Chiarini A; Sparatore F J Med Chem; 2010 Jun; 53(12):4668-77. PubMed ID: 20509610 [TBL] [Abstract][Full Text] [Related]
33. Organ selectivity of hexahydrosiladifenidol in blocking pre- and postjunctional muscarinic receptors studied in guinea-pig ileum and rat heart. Fuder H; Kilbinger H; Müller H Eur J Pharmacol; 1985 Jul; 113(1):125-7. PubMed ID: 3840090 [TBL] [Abstract][Full Text] [Related]
34. Himbacine recognizes a high affinity subtype of M2 muscarinic cholinergic receptors in the rat cerebral cortex. Wang JX; Roeske WR; Wang W; Yamamura HI Brain Res; 1988 Apr; 446(1):155-8. PubMed ID: 3370478 [TBL] [Abstract][Full Text] [Related]
35. The binding of agonists to brain muscarinic receptors. Birdsall NJ; Burgen AS; Hulme EC Mol Pharmacol; 1978 Sep; 14(5):723-36. PubMed ID: 714021 [No Abstract] [Full Text] [Related]
36. Synthesis of dibenzodioxazocines and their effects on cholinesterases and muscarinic cholinergic receptors. Gaál J; Batke J; Borsodi A; Rózsa L; Somogyi G Acta Biochim Biophys Hung; 1989; 24(1-2):129-42. PubMed ID: 2514534 [TBL] [Abstract][Full Text] [Related]
37. Hexocyclium derivatives with a high selectivity for smooth muscle muscarinic receptors. Micheletti R; Schiavone A; Cereda E; Donetti A Br J Pharmacol; 1990 May; 100(1):150-2. PubMed ID: 2372655 [TBL] [Abstract][Full Text] [Related]
38. Kinetic studies on muscarinic antagonist-agonist competition. Järv J; Hedlund B; Bartfai T J Biol Chem; 1980 Apr; 255(7):2649-51. PubMed ID: 7358694 [TBL] [Abstract][Full Text] [Related]
39. [Structure-activity relationship in the series of muscarinic acetylcholine receptor agonists: three types of agonist-receptor complexes]. Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS Bioorg Khim; 1985 Oct; 11(10):1391-401. PubMed ID: 4074399 [TBL] [Abstract][Full Text] [Related]
40. Antimuscarinic activities of hycanthone analogs: possible relationship with animal toxicity. Gordon RK; Chiang PK J Pharmacol Exp Ther; 1986 Jan; 236(1):85-9. PubMed ID: 3484525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]